Engineered Anthrax Lethal Toxin For Targeted Delivery Read more about Engineered Anthrax Lethal Toxin For Targeted Delivery US Application 61/692,143Filed on 2012-08-22
USE OF P47 FROM PLASMODIUM FALCIPARUM (PFS47) OR PLASMODIUM VIVAX (PVS47) AS A VACCINE OR DRUG SCREENING TARGETS FOR THE INHIBITION OF HUMAN MALARIA TRANSMISSION Read more about USE OF P47 FROM PLASMODIUM FALCIPARUM (PFS47) OR PLASMODIUM VIVAX (PVS47) AS A VACCINE OR DRUG SCREENING TARGETS FOR THE INHIBITION OF HUMAN MALARIA TRANSMISSION US Application 61/684,333Filed on 2012-08-17
CD-4 Mimetic Inhibitors Of HIV Entry And Methods Of Use Thereof Read more about CD-4 Mimetic Inhibitors Of HIV Entry And Methods Of Use Thereof US Application 61/570,536Filed on 2011-12-14
NOVEL HIV-1 BROADLY NEUTRALIZING ANTIBODIES Read more about NOVEL HIV-1 BROADLY NEUTRALIZING ANTIBODIES US Application 61/515,528Filed on 2011-08-05
Immune Based Treatment For Influenza Read more about Immune Based Treatment For Influenza US Application 61/538,427Filed on 2011-09-23
Immune Based Treatment For Influenza Read more about Immune Based Treatment For Influenza US Application 61/490,056Filed on 2011-05-25
A NOVEL SYNTHETIC PROMOTER FOR PROVIDING HIGH LEVEL A NOVEL SYNTHETIC PROMOTER FOR PROVIDING HIGH LEVEL TISSUE-SPECIFIC EXPRESSION Read more about A NOVEL SYNTHETIC PROMOTER FOR PROVIDING HIGH LEVEL A NOVEL SYNTHETIC PROMOTER FOR PROVIDING HIGH LEVEL TISSUE-SPECIFIC EXPRESSION US Application 61/664,518Filed on 2012-06-26
Self-Assembled Ferritin Nanoparticles Expressing Hemagglutinin As An Influenza Vaccine Read more about Self-Assembled Ferritin Nanoparticles Expressing Hemagglutinin As An Influenza Vaccine US Application 61/661,209Filed on 2012-06-18